Effect of Propofol vs. Sevoflurane on Erections During Narcosis In Transurethral Surgery
PENIS
Prospective, Randomized-Controlled Study of the Effect of Propofol vs. Sevoflurane on Erections During Narcosis in Transurethral Surgery
1 other identifier
interventional
200
1 country
1
Brief Summary
Penile erection is an unwanted event in transurethral (through the urethra) surgeries, which may be associated with adverse outcomes such as impaired access, prolonged operation time, the need to abort the operation, or the necessity for ancillary measures to achieve penile flaccidity, such as the injection of certain medications directly into the penis. To reduce greenhouse gas emissions, the primary use of propofol instead of gaseous agents is being recommended for general anesthesia. Whether propofol may be associated with an increased or decreased rate of unwanted intraoperative penile erection compared to other anesthetic agents is not known. More generally, there are no high-quality studies available to evaluate the impact of the type of general anesthesia on the risk of unwanted penile erections during surgery. This study aims to determine whether general anesthesia with propofol is more likely to cause intraoperative erections compared to sevoflurane during transurethral operations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Feb 2024
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 15, 2024
CompletedFirst Posted
Study publicly available on registry
April 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
April 22, 2024
April 1, 2024
2.8 years
April 15, 2024
April 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative Penile Erection
The primary endpoint "penile erection" will be analyzed as a binary outcome flaccid or erect. The occurrence of an erect penis at any time during surgery is classified as erect penile tumescence. Flaccid penile tumescence is classified only if erect penile tumescence does not occur at any point during the operation. The beginning and end of the operation are defined as the first insertion and last retrieval of all instruments, respectively. The penile tumescence will be reported in a simplified version of the validated EHS (erection hardness score): 0: flaccid, 1: increased tumescence, but not fully erect, 2: full erection. Erect penile tumescence is defined as achieving a score of either 1 or 2, whereas flaccid penile tumescence is defined as a score of 0.
Assessment during the operation and reporting before the end of the surgery.
Secondary Outcomes (6)
Prolongation of the surgery
Assessment during the operation and reporting before the end of the surgery.
Change in operative strategy
Assessment during the operation and reporting before the end of the surgery.
Adaptions of instruments or approaches
Assessment during the operation and reporting before the end of the surgery.
Altered operative outcome
Assessment during the operation and reporting before the end of the surgery.
Necessity for a drug application to decrease penile tumescence
Assessment during the operation and reporting before the end of the surgery.
- +1 more secondary outcomes
Study Arms (2)
Intervention group: Propofol
ACTIVE COMPARATORThe patients in the intervention group are receiving a general anesthesia with Propofol.
Control group: Sevoflurane
ACTIVE COMPARATORThe patients in the control group are receiving a general anesthesia with Sevoflurane.
Interventions
Transurethral surgery at the Department of Urology (University Hospital Zurich) performed under study arm-specific anesthesia. Propofol will be administered intravenously using the target-controlled infusion algorithm with effect site concentrations between 1.5-4.0 µg/ml necessary.
Transurethral surgery at the Department of Urology (University Hospital Zurich) performed under study arm-specific anesthesia. Sevoflurane will be given in gaseous form via the endotracheal tube in concentrations between 1.5-2.5% Vol.
Eligibility Criteria
You may qualify if:
- Planned transurethral operation in the department of urology.
- Preoperative IIEF-5 Score ≥12
- Planned surgery time ≥15min
You may not qualify if:
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
- Inability to provide informed consent.
- Contraindications to Propofol or Sevoflurane, e.g. known hypersensitivity or allergy.
- Known or suspected non-compliance, drug or alcohol abuse.
- Participation in another study with an investigational drug within the 30 days preceding and during the present study.
- Previous enrolment into the current study.
- Enrolment of the investigator, his/her family members, employees and other dependent persons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Zurich
Zurich, 8091, Switzerland
Related Publications (1)
Scherer TP, von Deschwanden C, Held U, Poyet C, Kwok JL, Kandler L, Schlapfer M, Keller EX, Schmid FA. Effect of Propofol Versus Sevoflurane on Erections during Narcosis in Transurethral Surgery: The PENIS Trial. Eur Urol Open Sci. 2024 Sep 24;69:100-104. doi: 10.1016/j.euros.2024.08.021. eCollection 2024 Nov.
PMID: 39381594DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Etienne X Keller, Ass Prof, MD
University Hospital Zurich, University of Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The authorized study nurse will hand the upcoming envelope with the treatment allocation to the anesthesiologist. The patient and the urologists (who is measuring the outcome) will not know which form of general anesthesia will be performed. Herewith, blankets in the operating room will hide installations used by the anesthesiologists to prevent the urologists witnessing the assigned narcosis form. Before the surgical sign-out, while still scrubbed in and with the patient under anesthesia, the anesthesiologists will ask the urologists about the outcome questionnaire. Together, they will fill in the paper case report form (CRF).
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 15, 2024
First Posted
April 22, 2024
Study Start
February 1, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
April 22, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- After successful publishing
- Access Criteria
- After successful publishing
After successful publishing, the data will be made available in anonymized form stored and in an open-access repository.